Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes Research Letter
| Authors: | Saliby, R. M.; Labaki, C.; Jammihal, T. R.; Xie, W.; Sun, M.; Shah, V.; Saad, E.; Kane, M. H.; Kashima, S.; Sadak, K.; El Zarif, T.; Poduval, D.; Motzer, R. J.; Powles, T.; Rini, B. I.; Albiges, L.; Pal, S. K.; McGregor, B. A.; McKay, R. R.; Signoretti, S.; Van Allen, E. M.; Shukla, S. A.; Choueiri, T. K.; Braun, D. A. |
| Title: | Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes |
| Keywords: | immunohistochemistry; treatment outcome; genetics; bevacizumab; sunitinib; letter; demography; ipilimumab; cancer immunotherapy; gene expression; risk factor; renal cell carcinoma; kidney neoplasms; immunology; immunotherapy; kidney tumor; carcinoma, renal cell; antiangiogenic therapy; axitinib; t lymphocyte activation; molecularly targeted therapy; clinical outcome; molecular targeted therapy; procedures; machine learning; immune checkpoint inhibitor; cancer prognosis; cabozantinib; nivolumab; humans; human; differential expression analysis; immune checkpoint inhibitors; atezolizumab; avelumab |
| Journal Title: | Cancer Cell |
| Volume: | 42 |
| Issue: | 5 |
| ISSN: | 1535-6108 |
| Publisher: | Cell Press |
| Date Published: | 2024-05-13 |
| Start Page: | 732 |
| End Page: | 735 |
| Language: | English |
| DOI: | 10.1016/j.ccell.2024.03.002 |
| PUBMED: | 38579722 |
| PROVIDER: | scopus |
| PMCID: | PMC11130783 |
| DOI/URL: | |
| Notes: | Letter -- Source: Scopus |
